We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$4.11B
1-Year Est. Return
26.03%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+26.03%
3 Year Est. Return
+55.81%
5 Year Est. Return
+76.4%
10 Year Est. Return
+190.66%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-14.9%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.09% |
| 2 | Consumer Staples | 9.92% |
| 3 | Healthcare | 9.5% |
| 4 | Technology | 7.01% |
| 5 | Consumer Discretionary | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
351
CALL
DELISTED
Aetna Inc
AET
| $2.03M | 0.02% |
25,000
-2,300
| -8% | -$174K |
|
352
American Tower
AMT
$83.4B
| $2.03M | 0.02% |
22,522
-16,580
| -42% | -$1.43M |
|
353
Waste Management
WM
$86.6B
| $2.03M | 0.02% |
45,292
+34,596
| +323% | +$1.51M |
|
354
American Electric Power
AEP
$66B
| $2.01M | 0.02% |
36,026
-126,999
| -78% | -$6.7M |
|
|
VVC
355
DELISTED
Vectren Corporation
VVC
| $2.01M | 0.02% |
47,240
-80,589
| -63% | -$3.22M |
|
|
EMC
356
CALL
DELISTED
EMC CORPORATION
EMC
| $1.99M | 0.02% |
75,700
+67,700
| +846% | +$1.79M |
|
|
LPT
357
DELISTED
Liberty Property Trust
LPT
| $1.95M | 0.02% |
+51,408
| New | +$1.95M |
|
358
CALL
KB Home
KBH
$3.04B
| $1.95M | 0.02% |
104,200
+81,200
| +353% | +$1.36M |
|
|
JOBS
359
DELISTED
51job Inc
JOBS
| $1.95M | 0.02% |
+59,000
| New | +$1.93M |
|
360
Deere & Co
DE
$182B
| $1.93M | 0.02% |
+21,335
| New | +$1.96M |
|
361
Red Robin
RRGB
$142M
| $1.91M | 0.02% |
+26,806
| New | +$1.87M |
|
362
PUT
Celldex Therapeutics
CLDX
$3.06B
| $1.9M | 0.02% |
+7,760
| New | +$1.75M |
|
363
Autodesk
ADSK
$46.5B
| $1.88M | 0.02% |
+33,429
| New | +$1.7M |
|
364
Vale
VALE
$61.1B
| $1.88M | 0.02% |
+141,869
| New | +$1.91M |
|
|
ACC
365
DELISTED
American Campus Communities, Inc.
ACC
| $1.88M | 0.02% |
49,032
+1,069
| +2% | +$40.9K |
|
366
CALL
Pfizer
PFE
$157B
| $1.87M | 0.02% |
66,402
-21,607
| -25% | -$616K |
|
367
Akamai
AKAM
$15.2B
| $1.87M | 0.02% |
30,614
-4,084
| -12% | -$227K |
|
|
AFAM
368
PUT
DELISTED
Almost Family Inc
AFAM
| $1.85M | 0.02% |
83,900
+74,600
| +802% | +$1.62M |
|
369
Sarepta Therapeutics
SRPT
$2.13B
| $1.84M | 0.02% |
+61,915
| New | +$1.96M |
|
|
ZNGA
370
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.8M | 0.02% |
560,748
+499,591
| +817% | +$1.81M |
|
371
Sysco
SYY
$38.2B
| $1.8M | 0.02% |
+47,993
| New | +$1.76M |
|
372
Murphy Oil
MUR
$5.56B
| $1.79M | 0.02% |
+26,993
| New | +$1.69M |
|
|
SUNE
373
PUT
DELISTED
SUNEDISON, INC COM
SUNE
| $1.75M | 0.02% |
+77,600
| New | +$1.51M |
|
374
CALL
lululemon athletica
LULU
$10.9B
| $1.74M | 0.02% |
+43,000
| New | +$1.96M |
|
375
PUT
Vera Bradley
VRA
$118M
| $1.72M | 0.02% |
+78,400
| New | +$2.06M |
|
Similar funds
DS
GCC
BHC
BB
DWP
PL
JIM
FMII
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $1.22B in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.